Do you want to read an article? Please log in or register.
Is Neoadjuvant Chemoimmunotherapy Safe in Surgically High-Risk Lung Cancer Patients? A Single-Centre IPTW Analysis
Lung Cancer
Related content
Lung Cancer
A Multi-Institutional Randomized Phase III Trial of Neoadjuvant Chemoimmunotherapy Followed By Surgery Versus Upfront Surgery in Patients With Resectable Clinical Stage II-III Non-Small Cell Lung Cancer: JCOG2317 (NATCH-ICI)
Clin Lung Cancer
Mitome N, Hamada A, Wakabayashi M, Uozumi T, Horinouchi H, Isaka M, Yotsukura M, Aokage K, Fukuda H, Watanabe SI, Tsutani Y, Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group (JCOG)
doi: 10.1016/j.cllc.2026.04.006
Further Publications
Neoadjuvant chemoimmunotherapy in non-small-cell lung cancer patients: Effects on pulmonary function and incidence of postoperative pulmonary complications-a multicenter real-world study
Eur J Cardiothorac Surg
Zhang J, Feng Y, Dai S, Xu G, Cheng B, Jiang L, Xue LP, Liang W, Tang J
doi: 10.1093/ejcts/ezaf351
RECOMMENDED
Lung Cancer
Trastuzumab Deruxtecan in Patients From China With Pretreated HER2-Mutant Non-Small Cell Lung Cancer: Final Analysis of the Phase 2, Single-Arm DESTINY-Lung05 Trial
★ 1
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Clin Lung Cancer
Liu Y, Li D, Wu L, Li X, Fan Y, Zhang M, Guo J, Yao Y, Fang J, Tang KJ, Luo F, Yu Y, Min X, Song Z, Hu J, Ma R, Yang H, Shu Y, Xu R, Wang B, Dong X, Chen Y, Mao R, Zhang V, Fang Y
doi: 10.1016/j.cllc.2026.06.003
Lung Cancer
High penetrance rare variants underlying familial lung cancer risk: Insights from genetic epidemiology of lung cancer consortium
J Thorac Oncol
Liu Y, Li Y, Byun J, Shaw VR, Pikielny C, Peng B, Cheng C, Tsavachidis S, Xiao X, Zhu D, Han Y, Gorlov IP, Gorlova OY, Cole M, Gaba CR, Crawford EL, Purrington K, Goode EL, Yang P, McKay J, Field JK, Liu G, Hung RJ, Xia J, Choi J, Schabath MB, LoPiccolo J, Christiani DC, Bailey-Wilson J, Schwartz AG, Willey JC, Mandal D, Pinney SM, Amos CI
doi: 10.1016/j.jtho.2025.12.004
Lung Cancer
Sex-specific efficacy and safety outcomes in patients with resectable stage III non-small-cell lung cancer (NSCLC) undergoing neoadjuvant therapies: a pooled analysis of the SAKK trials 16/96, 16/00, 16/01, 16/08 and 16/14
ESMO Open
Frehner L, Schär S, Hayoz S, Guckenberger M, Finazzi T, Mark M, Addeo A, Mauti LA, Betticher D, Stupp R, Curioni-Fontecedro A, Peters S, Früh M, Rothschild SI, Pless M, König D, Opitz I, Ris HB, Özdemir BC, Schmid S
doi: 10.1016/j.esmoop.2025.105870
Lung Cancer
Club cell secretory protein (CCSP) serum concentration is a prognostic factor after surgical resection of localized non-small cell lung cancer in patients in the IFCT-0302 trial
Lung Cancer
Brosseau S, Etienne H, Peoc'h K, Langlais A, Blanché H, Foucher P, Barlesi F, Domas J, Girard P, Scherpereel A, Dumont P, Derollez M, Quoix E, Debieuvre D, Deleuze JF, Leçon-Malas V, Zalcman G, Westeel V, Mordant P
doi: 10.1016/j.lungcan.2026.109345
RECOMMENDED
Lung Cancer
Chemoimmunotherapy Versus Chemotherapy for Extensive-Stage Small Cell Lung Cancer in the Real-World Setting: Retrospective Study of 904 Patients
★ 2
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Clin Lung Cancer
Dimitriou K, Shi S, Marginenau A, Blasi M, Bozorgmehr F, Klotz LV, Eichhorn F, Schneider MA, Allgäuer M, Shah R, Bischoff H, Weykamp F, Stenzinger A, Thomas M, Christopoulos P
doi: 10.1016/j.cllc.2026.06.004
Lung Cancer
Real-world evaluation of the christie symptom inventory-lung cancer (CSI-lung) electronic patient-reported outcome measure: validity, reliability, responsiveness, and patient experiences
Lung Cancer
Nuamek T, Liao K, Ward A, Devaraj RL, Price J, Noon K, Taylor S, Faivre-Finn C, Yorke J
doi: 10.1016/j.lungcan.2026.109564
Lung Cancer
Associations between Prior Lung Diseases and Risk of Lung Cancer in Populations With No Smoking History: A Systematic Review and Meta-Analysis
Chest
Swami N, Hong JH, Kho S, Kang HM, Chun-Chia Lin L, Ni SC, Florez N, Lan Q, Rothman N, Dee EC, Gomez SL, Cheng I
doi: 10.1016/j.chest.2025.12.034